ConductScience.org, home

Paper37592141

Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis.

Ucar D and 9 others. Rheumatol Int, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis. Papers, record 37592141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37592141

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis.
PubMed
Journal
Rheumatol Int
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2026-10-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Behcet SyndromeMajor topic
UveitisMajor topic
Humans
Mycophenolic Acid
Retrospective Studies
Immunosuppressive Agents

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128450313Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.Ann Rheum Dis2017https://conductscience.org/library/papers/28450313PubMed
22404204A controlled trial of azathioprine in Behçet's syndrome.N Engl J Med1990https://conductscience.org/library/papers/2404204PubMed
321699532Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases.Int J Dermatol2011https://conductscience.org/library/papers/21699532PubMed
427469583Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Lancet Respir Med2016https://conductscience.org/library/papers/27469583PubMed
530107448Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.Rheumatology (Oxford)2018https://conductscience.org/library/papers/30107448PubMed
619748676Methotrexate for ocular inflammatory diseases.Ophthalmology2009https://conductscience.org/library/papers/19748676PubMed
736255985Uveitis in Behçet disease - an update.Curr Opin Rheumatol2023https://conductscience.org/library/papers/36255985PubMed
820665749Azathioprine in severe uveitis of Behçet's disease.Arthritis Care Res (Hoboken)2010https://conductscience.org/library/papers/20665749PubMed
933335139A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet's syndrome.Sci Rep2020https://conductscience.org/library/papers/33335139PubMed
1030612116Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.Ann Rheum Dis2019https://conductscience.org/library/papers/30612116PubMed
1126162757Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.J Autoimmun2015https://conductscience.org/library/papers/26162757PubMed
1228860798Behçet's syndrome: providing integrated care.J Multidiscip Healthc2017https://conductscience.org/library/papers/28860798PubMed
1330747365Phenotypes in Behçet's syndrome.Intern Emerg Med2019https://conductscience.org/library/papers/30747365PubMed
1436458741Current pharmacological solutions for Behçet's syndrome.Expert Opin Pharmacother2023https://conductscience.org/library/papers/36458741PubMed
1516196117Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.Am J Ophthalmol2005https://conductscience.org/library/papers/16196117PubMed
1619369404Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.J Am Soc Nephrol2009https://conductscience.org/library/papers/19369404PubMed
17296259682018 update of the EULAR recommendations for the management of Behçet's syndrome.Ann Rheum Dis2018https://conductscience.org/library/papers/29625968PubMed
1820042178Mycophenolate mofetil for ocular inflammation.Am J Ophthalmol2010https://conductscience.org/library/papers/20042178PubMed
1912544711The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.Medicine (Baltimore)2003https://conductscience.org/library/papers/12544711PubMed
2021968239Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases.Clin Exp Rheumatol2011https://conductscience.org/library/papers/21968239PubMed

See all 32 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41776676Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial.Arthritis Res Ther2026https://conductscience.org/library/papers/41776676PubMed
41396112Can mycophenolate mofetil be an effective option in the treatment of vascular Behçet's Syndrome.Sarcoidosis Vasc Diffuse Lung Dis2025https://conductscience.org/library/papers/41396112PubMed
40182974Behçet syndrome with eye involvement.Saudi J Ophthalmol2025https://conductscience.org/library/papers/40182974PubMed
37995045Disease and Treatment-Specific Complications of Behçet Syndrome.Curr Rheumatol Rep2024https://conductscience.org/library/papers/37995045PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37592141

GET https://conductscience.org/api/papers/v1/37592141/references?page=2